Virtual Remote Physiological Monitoring Program of Children With Heart Disease

NACompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

February 8, 2022

Primary Completion Date

September 30, 2024

Study Completion Date

January 10, 2025

Conditions
Pediatric ALLCongenital Heart DiseaseSingle-ventricleBiventricular Congestive Heart FailureHeart FailureHeart Failure,CongestiveTransplant; Failure, Heart
Interventions
DEVICE

Remote physiological monitoring

Participants will be provided with a Bluetooth capable weight scale (A\&D Medical UC-352BLE or Beurer BY90), oxygen saturation monitor (Contec Medical Systems CMS50D-BT) and automatic blood pressure monitor (A\&D Medical UA- 651BLE) to use daily for at least 10 days of a 14-day trial period. Data will be sent via the Sphygmo App to the pediatric cardiology for monitoring. Parents and healthcare providers will be asked to participate in a qualitative interview and the end of the 14-day period to provide feedback on the devices and Sphygmo™ platform.

Trial Locations (1)

T6G 2B7

University of Alberta, Edmonton

All Listed Sponsors
lead

University of Alberta

OTHER